They discovered that palmitic acid, a metabolite of CAAs, enhanced the tumor initiation of breast cancer cells in a transcription factor CCAAT/enhancer-binding protein beta (C/EBPB)-dependent manner 185. The gene discussed is CEBPB; the disease is breast cancer.